EVOFEM BIOSCIENCES, INC. — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+34.6% +$2M
$10M
Cost of Revenue↑+71.4% +$1M
$3M
R&D
$649K
D&A↑+0.0% +$0
$5K
Operating Income
$2M
EBITDA↑+48420.0% +$2M
$2M
Interest Expense↑+6.3% +$36K
$606K
Interest Income↓-33.3% -$1K
$2K
Other Income/Expense
$149K
Pretax Income
$2M
Tax Provision↑+50.0% +$4K
$-4K
Net Income
$2M
Operating Margin
25.3%
Net Margin
20.5%
Effective Tax Rate↓-0.1pts
0.3%
ETR (Continuing Operations)
0.5%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
3.2%
ETR Foreign Differential (pp)
—
Operating Lease Cost↓-9.1% -$4K
$40K
Revenue YoY Variation↓-12.2pts
34.6%
Income YoY Variation
139.0%
Revenue QoQ Variation↑+35.1pts
93.1%
Income QoQ Variation
154.6%